Literature DB >> 1365640

Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens.

L D McCullough1, J D Salamone.   

Abstract

Two experiments were conducted to study the effects of anxiogenic drugs on dopamine release and metabolism in nucleus accumbens. Microdialysis probes were implanted into the nucleus accumbens, and rats were tested the day after implantation. In the first experiment, groups of rats received injections of saline, 1.25 or 2.5 mg/kg beta-CCE. In the second experiment, groups of rats received injections of saline, 10.0, 20.0 or 30.0 mg/kg FG-7142. Both drugs produced significant increases in dopamine release and metabolism in nucleus accumbens. Neither drug had significant effects on locomotor activity. These experiments indicate that exposure to anxiogenic drugs increases accumbens dopamine activity, an effect that is consistent with other studies showing that the mesolimbic dopamine system is responsive to stressful stimuli. In addition, these results demonstrate that drug-induced increases in accumbens dopamine release are not unique to drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365640     DOI: 10.1007/bf02245888

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum.

Authors:  B Moghaddam; R H Roth; B S Bunney
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

3.  Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors.

Authors:  R Dorow; R Horowski; G Paschelke; M Amin
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

4.  Intrinsic and antagonistic effects of beta-carboline FG 7142 on behavioral and EEG actions of benzodiazepines and pentobarbital in cats.

Authors:  E Ongini; C Barzaghi; M Marzanatti
Journal:  Eur J Pharmacol       Date:  1983-11-11       Impact factor: 4.432

5.  Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.

Authors:  C Braestrup; M Nielsen; C E Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

Review 6.  Mesocorticolimbic dopaminergic systems and emotional states.

Authors:  M Bertolucci-D'Angio; A Serrano; B Scatton
Journal:  J Neurosci Methods       Date:  1990-09       Impact factor: 2.390

7.  Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex.

Authors:  E D Abercrombie; K A Keefe; D S DiFrischia; M J Zigmond
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

8.  Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor.

Authors:  N J Leidenheimer; M D Schechter
Journal:  Pharmacol Biochem Behav       Date:  1988-06       Impact factor: 3.533

9.  Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study.

Authors:  L D McCullough; J D Salamone
Journal:  Brain Res       Date:  1992-10-02       Impact factor: 3.252

10.  Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam.

Authors:  F Fadda; A Argiolas; M R Melis; A H Tissari; P L Onali; G L Gessa
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

View more
  16 in total

1.  Fear and feeding in the nucleus accumbens shell: rostrocaudal segregation of GABA-elicited defensive behavior versus eating behavior.

Authors:  S M Reynolds; K C Berridge
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

2.  Benzodiazepine prevention of swim stress-induced sensitization of cortical biogenic amines: an in vivo microdialysis study.

Authors:  F Petty; S Jordan; G L Kramer; P K Zukas; J Wu
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

Review 3.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

Review 4.  Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction.

Authors:  Chiang-shan Ray Li; Rajita Sinha
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

Review 5.  A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

Authors:  Jennifer M Wenzel; Noah A Rauscher; Joseph F Cheer; Erik B Oleson
Journal:  ACS Chem Neurosci       Date:  2014-12-24       Impact factor: 4.418

6.  Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

Authors:  K S Sink; K N Segovia; J Sink; P A Randall; L E Collins; M Correa; E J Markus; V K Vemuri; A Makriyannis; J D Salamone
Journal:  Eur Neuropsychopharmacol       Date:  2009-12-16       Impact factor: 4.600

Review 7.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents.

Authors:  J Fadel; H Moore; M Sarter; J P Bruno
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

Review 9.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

10.  Dopamine, behavioral economics, and effort.

Authors:  John D Salamone; Merce Correa; Andrew M Farrar; Eric J Nunes; Marta Pardo
Journal:  Front Behav Neurosci       Date:  2009-09-07       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.